Impact of prostate volume on the active surveillance in prostate cancer

被引:0
|
作者
Beaujouan, Florent [1 ]
Bertherat, Walter [2 ]
Hammoudi, Zakaria [1 ]
Chicaud, Marie [1 ]
Descazeaud, Aurelien [1 ]
机构
[1] Univ Hosp Ctr Dupuytren, Dept Urol Surg & Androl, 16 rue Petiniaud-Beaupeyrat, F-87000 Limoges, France
[2] Perigueux Hosp Ctr, Dept Urol Surg & Androl, Perigueux, France
关键词
Prostatic neoplasms; active surveillance; prostate-specific antigen; prostatic hyperplasia; prognostic factors; FOLLOW-UP; ANTIGEN KINETICS; GUIDELINES; MANAGEMENT; DIAGNOSIS; OUTCOMES; PREDICT; UPDATE; BIOPSY; COHORT;
D O I
10.1177/20514158241303972
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the influence of the prostate volume (PVo) in the management of patients in active surveillance (AS) for prostate cancer. Materials and methods: A retrospective analysis of clinical, biological, histological and radiological data collected between 2010 and 2021 was performed for patients included in an AS protocol in a university hospital. The impact of initial PVo on the subsequent risk of exiting AS was evaluated. Results: In total, 109 patients were included in this analysis with a mean follow-up period of 52.74 +/- 31 months, 50% were out of AS by the end of the follow-up period. The risk of exiting the AS protocol was significantly associated to the PVo: patients with smaller PVo had an increased risk of exiting AS (p = 0.025). The maximal percentage of core invasion was the only initial predictive parameter for exiting the AS protocol on multivariate analysis of the global cohort (p = 0.010) and in the sub-group of patients having PVo <= 45 mL (p = 0.013). In the group having a PVo > 45 mL, no single initial parameter was significantly associated to a risk of exiting AS. Conclusion: Patients having small-sized prostate seemed to be at higher risk of exiting AS during follow-up.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Active surveillance of prostate cancer
    Ploussard, G.
    Hennequin, C.
    Rozet, F.
    CANCER RADIOTHERAPIE, 2017, 21 (6-7): : 437 - 441
  • [2] Active surveillance of prostate cancer
    Bolenz, Christian
    Grimm, Marc-Oliver
    Heidenreich, Axel
    Kristiansen, Glen
    Schimmoeller, Lars
    Schmidt, Stefanie
    Schostak, Martin
    Hadaschik, Boris
    UROLOGIE, 2025,
  • [3] Guy's and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
    Shah, Salonee
    Beckmann, Kerri
    Van Hemelrijck, Mieke
    Challacombe, Ben
    Popert, Rick
    Dasgupta, Prokar
    Rusere, Jonah
    Zisengwe, Grace
    Elhage, Oussama
    Santaolalla, Aida
    BMC CANCER, 2021, 21 (01)
  • [4] Active surveillance for prostate cancer
    Romero-Otero, Javier
    Garcia-Gomez, Borja
    Duarte-Ojeda, Jose M.
    Rodriguez-Antolin, Alfredo
    Vilaseca, Antoni
    Carlsson, Sigrid V.
    Touijer, Karim A.
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (03) : 211 - 218
  • [5] Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes
    Ahlberg, Mats S.
    Garmo, Hans
    Holmberg, Lars
    Bill-Axelson, Anna
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 52 : 166 - 173
  • [6] Active surveillance and surgery in localized prostate cancer
    Kwon, O.
    Hong, S. K.
    MINERVA UROLOGICA E NEFROLOGICA, 2014, 66 (03) : 175 - 187
  • [7] Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
    An, Julie Y.
    Sidana, Abhinav
    Choyke, Peter L.
    Wood, Bradford J.
    Pinto, Peter A.
    Turkbey, Ismail Baris
    BALKAN MEDICAL JOURNAL, 2017, 34 (05) : 388 - 396
  • [8] Evidence-based approach to active surveillance of prostate cancer
    Witherspoon, Luke
    Breau, Rodney H.
    Lavallee, Luke T.
    WORLD JOURNAL OF UROLOGY, 2020, 38 (03) : 555 - 562
  • [9] Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes
    Cooperberg, Matthew R.
    Brooks, James D.
    Faino, Anna, V
    Newcomb, Lisa F.
    Kearns, James T.
    Carroll, Peter R.
    Dash, Atreya
    Etzioni, Ruth
    Fabrizio, Michael D.
    Gleave, Martin E.
    Morgan, Todd M.
    Nelson, Peter S.
    Thompson, Ian M.
    Wagner, Andrew A.
    Lin, Daniel W.
    Zheng, Yingye
    EUROPEAN UROLOGY, 2018, 74 (02) : 211 - 217
  • [10] Quality of care and economic considerations of active surveillance of men with prostate cancer
    Filson, Christopher P.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (02) : 203 - 213